The Super Bowl is no longer just a football event — it’s the most expensive billboard in American culture, and in 2026, that billboard is plastered with AI hype, weight-loss drugs, and celebrities selling you both. What happens in those 30-second slots tells you everything about where tech money is flowing and who the industry thinks is dumb enough to follow it.
Super Bowl LIX just aired, and if you watched the commercials — which, let’s be honest, half of America tunes in specifically for — you saw a very clear picture of 2026’s tech obsession. According to ABC7, this year’s ad slate was dominated by three things: artificial intelligence, GLP-1 weight-loss drugs, and enough celebrity faces to fill a mediocre awards show. The combination isn’t accidental. It’s a $7 million-per-30-seconds bet on what American consumers will open their wallets for in 2026.
AI Ads Were Everywhere — And Mostly Empty
Tech companies spent obscene money to tell you AI is here. Not to show you what it does. Not to explain how your life changes. Just to say: AI. Here. Trust us.
OpenAI ran its first-ever Super Bowl spot. Meta pushed its AI assistant. Google leaned hard into Gemini. The ads were polished, emotional, and almost completely devoid of substance. They showed people smiling at screens. Warm lighting. Inspiring music. Zero specifics.
This is the celebrity startup playbook dressed up in tech clothing. Attach a famous face or a famous brand to a vague promise, buy the biggest stage on earth, and watch the valuations climb. The AI gold rush has matured past “build something useful” and arrived at “market something aspirational.” That’s a warning sign, not a milestone.
What’s telling is that none of these ads targeted developers, engineers, or technically literate users. They targeted everyone else. The pitch isn’t capability anymore — it’s comfort. AI wants to seem like a trustworthy friend, not a powerful tool. That reframing has enormous implications for how these products get regulated, and how users understand what they’re actually agreeing to when they click “enable.” The White House AI Deal Would Override State Laws, Mandate Age Verification — a move that fits perfectly into this world where AI companies want federal cover while they normalize mass adoption through Super Bowl soft-sells.
Weight-Loss Drugs Bought the Other Half of the Game
Pharmaceutical companies running Super Bowl ads isn’t new. But the sheer volume of GLP-1 and weight-loss drug spots in 2026 signals something bigger. Ozempic and its competitors aren’t just medications anymore — they’re lifestyle brands competing directly with fitness apps, meal-kit services, and wellness platforms for the same anxious consumer dollar.
The irony is brutal and worth saying out loud. We already know that people taking GLP-1 weight-loss drugs like Ozempic started moving less — which raises real questions about the long-term trade-offs of a culture that would rather inject than exercise. Running those ads between NFL plays, where physical peak performance is the entire point, is either bold irony or complete cognitive dissonance. Probably both.
The tech angle here is real. These drug companies are increasingly merging with health tech platforms, wearables, and AI-driven coaching apps. The Super Bowl ad isn’t just a pharma flex — it’s a customer acquisition play for an entire ecosystem of subscription health services built around the drug. You take the shot, you download the app, you subscribe to the meal plan. It’s a funnel with a syringe at the top.
Celebrities Are Still the Laziest Marketing Strategy That Works
Every year the industry swears it’s moving past celebrity endorsements toward authentic product stories. Every year the Super Bowl proves that wrong.
Ben Affleck, Post Malone, Beckham — faces move product. Period. For celebrity-backed startups and tech ventures specifically, a single Super Bowl appearance can do what years of product development couldn’t: make something feel legitimate. This is the same psychology that powers creator economies, which is exactly why the most profitable platforms for creators in 2026 are the ones that figured out parasocial trust before their competitors did. Familiarity is currency. Celebrities are a shortcut to buying it.
The problem is that startups addicted to celebrity credibility often skip the harder work of building products that hold up without the spotlight. When the Super Bowl buzz fades — and it always does — users are left with whatever the actual product is. In 2026, for too many of these companies, that product is still in beta.
The Hot Take
The best thing that could happen to AI right now is a complete ban on AI companies advertising to general consumers until they can explain in plain language what their product does, what data it collects, and what happens when it gets it wrong. The Super Bowl AI ad blitz isn’t education — it’s inoculation. It’s making the public comfortable with something they don’t understand, which benefits the companies and no one else. Informed consent doesn’t make great television, but it makes better technology adoption. The industry will never self-impose this standard, which means regulators need to stop admiring the problem and start acting like they’ve seen one before.
Super Bowl LIX’s ads aren’t just entertainment noise. They’re a clear-eyed look at where billions in tech and pharma capital are headed in 2026: toward mass consumer comfort, not mass consumer empowerment. When the most expensive ad slots on earth are selling you on AI you can’t evaluate and drugs with trade-offs you won’t read about until after the game, the product isn’t the technology — it’s you, convinced enough to buy in before asking the right questions.